Search by Drug Name or NDC
NDC 29978-0128-10 Capron DMT 30; 30 mg/1; mg/1 Details
Capron DMT 30; 30 mg/1; mg/1
Capron DMT is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Capital Pharma. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; PYRILAMINE MALEATE.
Product Information
NDC | 29978-0128 |
---|---|
Product ID | 29978-128_a0ad8dcd-58ed-e3fe-e053-2a95a90a21fa |
Associated GPIs | 43995702700320 |
GCN Sequence Number | 077308 |
GCN Sequence Number Description | pyrilamine/dextromethorphan hb TABLET 30 MG-30MG ORAL |
HIC3 | B4E |
HIC3 Description | NON-OPIOID ANTITUSSIVE-1ST GEN ANTIHISTAMINE COMB. |
GCN | 43282 |
HICL Sequence Number | 040243 |
HICL Sequence Number Description | PYRILAMINE MALEATE/DEXTROMETHORPHAN HBR |
Brand/Generic | Brand |
Proprietary Name | Capron DMT |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Dextromethorphan HBr and Pyrilamine Maleate |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 30; 30 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; PYRILAMINE MALEATE |
Labeler Name | Capital Pharma |
Pharmaceutical Class | Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Listing Certified Through | 2022-12-31 |
Package
Package Images


NDC 29978-0128-10 (29978012810)
NDC Package Code | 29978-128-10 |
---|---|
Billing NDC | 29978012810 |
Package | 100 TABLET in 1 BOTTLE, PLASTIC (29978-128-10) |
Marketing Start Date | 2017-01-26 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 50222df4-5c31-1304-e054-00144ff88e88 Details
Directions
Other information
Active ingredients (in each tablet)
Uses
Do not exceed recommended dosage.
- May cause drowsiness; alcohol, sedatives, and tranquilizers may increase the drowsiness effect. Avoid alcoholic beverages while taking this product. Do not take this product if you are taking sedatives or tranquilizers, without first consulting your doctor. Use caution when driving a motor vehicle or operating machinery.
Do not use this product
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
Stop use and ask doctor if
Keep out of reach of children.
INGREDIENTS AND APPEARANCE
CAPRON DMT
dextromethorphan hbr and pyrilamine maleate tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - Capital Pharma (831545541) |
Revised: 3/2020
Document Id: a0ad8dcd-58ed-e3fe-e053-2a95a90a21fa
Set id: 50222df4-5c31-1304-e054-00144ff88e88
Version: 2
Effective Time: 20200312